- Home
- ERII vs BBOT Comparison
ERII vs BBOT Comparison
Compare ERII & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERII
- BBOT
- Stock Information
- Founded
- ERII 1992
- BBOT N/A
- Country
- ERII United States
- BBOT United States
- Employees
- ERII N/A
- BBOT N/A
- Industry
- ERII Industrial Machinery/Components
- BBOT Biotechnology: Pharmaceutical Preparations
- Sector
- ERII Technology
- BBOT Health Care
- Exchange
- ERII Nasdaq
- BBOT Nasdaq
- Market Cap
- ERII 762.9M
- BBOT 822.9M
- IPO Year
- ERII 2008
- BBOT N/A
- Fundamental
- Price
- ERII $14.62
- BBOT $10.79
- Analyst Decision
- ERII Buy
- BBOT Strong Buy
- Analyst Count
- ERII 4
- BBOT 4
- Target Price
- ERII $18.75
- BBOT $25.00
- AVG Volume (30 Days)
- ERII 369.5K
- BBOT 225.0K
- Earning Date
- ERII 10-29-2025
- BBOT 01-01-0001
- Dividend Yield
- ERII N/A
- BBOT N/A
- EPS Growth
- ERII 25.10
- BBOT N/A
- EPS
- ERII 0.43
- BBOT N/A
- Revenue
- ERII $141,775,000.00
- BBOT N/A
- Revenue This Year
- ERII $6.16
- BBOT N/A
- Revenue Next Year
- ERII $13.06
- BBOT N/A
- P/E Ratio
- ERII $34.28
- BBOT N/A
- Revenue Growth
- ERII 6.19
- BBOT N/A
- 52 Week Low
- ERII $10.86
- BBOT $8.70
- 52 Week High
- ERII $20.27
- BBOT $12.50
- Technical
- Relative Strength Index (RSI)
- ERII 56.27
- BBOT N/A
- Support Level
- ERII $14.20
- BBOT N/A
- Resistance Level
- ERII $14.65
- BBOT N/A
- Average True Range (ATR)
- ERII 0.35
- BBOT 0.00
- MACD
- ERII -0.01
- BBOT 0.00
- Stochastic Oscillator
- ERII 67.00
- BBOT 0.00
About ERII Energy Recovery Inc.
Energy Recovery Inc is an engineering-driven technology company. It is engaged in engineering, designing, manufacturing and supplying solutions that make industrial processes more efficient and sustainable. The company operates in three segments, Water, Emerging Technologies and Corporate. It offers energy recovery devices (ERDs) and pumps as well as related products and services to the reverse osmosis desalination market. The company derives a majority of the revenue from the Water segment. Geographically, the company operates in the U.S. and other international countries.
About BBOT BridgeBio Oncology Therapeutics Inc. Common Stock
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.